Abiopharma

🔍 Hsieh Anthony Li (Director)

Company: loanDepot, Inc. (LDI)

Report Date: 2026-08-26

Detailed Transactions and Holdings:

• Acquired 284,349 shares of Class A Common Stock at $0.8898 per share (Direct)
  Date: 2026-08-26 | Code: P | equity_swap_involved: 0 | shares_owned_after: 755,815.00 | transaction_form_type: 4 | Footnotes: F1, F2
• Acquired 38,612 shares of Class A Common Stock at $0.939 per share (Direct)
  Date: 2026-08-27 | Code: P | equity_swap_involved: 0 | shares_owned_after: 794,427.00 | transaction_form_type: 4 | Footnotes: F3, F2
• Holds 0 shares of Class A Common Stock (Direct)
  Date: 2026-08-26 | Code: H | shares_owned_after: 217,496.00

Footnotes:

• F1: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.8757 to $0.9281. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth in this footnote of this Form 4 at which the respective transactions were affected.
• F2: As trustee, Anthony Hsieh has voting and investment power over the assets of The JLSSAA Trust ("JLSSAA Trust").
• F3: The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $0.8929 to $0.9500. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, specific trade amounts and pricing within the ranges set forth in this footnote of this Form 4 at which the respective transactions were affected.